Shingles (Herpes Zoster) Vaccination Information for Healthcare Providers
CDC vaccination recommendations, and the contraindications and precautions for Shingrix vaccination
Information about Shingrix vaccine composition, dosage, and administration, and vaccine efficacy, duration of protection, reactogenicity
Answers to commonly asked questions about the new shingles vaccine
Information about Shingrix vaccine storage and handling
Information about administering Shingrix with other vaccines, and how to avoid vaccine administration errors
Materials for patients and resources for healthcare providers
- Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022.
- Clinical Considerations for Use of Recombinant Zoster Vaccine (RZV, Shingrix) in Immunocompromised Adults Aged ≥19 Years | CDC
- Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines, 2018.
- Shingles Vaccine Information Statement (Shingrix)